Literature DB >> 10231441

Binding of human neutrophils to cell-surface anchored Tamm-Horsfall glycoprotein in tubulointerstitial nephritis.

D Cavallone1, N Malagolini, F Serafini-Cessi.   

Abstract

BACKGROUND: Human Tamm-Horsfall glycoprotein (T-H) is a glycosylphosphatidylinositol-anchored protein exposed at the surface of distal nephron cells, and urinary T-H is the released soluble counterpart. The latter has been implicated in tubulointerstitial nephritis, and the proinflammatory potential has been related to its ability to bind in vitro human neutrophils (PMNs). We have examined the conditions required for the binding of neutrophils to cell-surface anchored T-H and the consequent effects.
METHODS: A HeLa cell-line derivative permanently transformed with human T-H cDNA and expressing T-H at the cell surface was used throughout the study. The adhesion of PMNs to cells expressing T-H was analyzed by immunofluorescence microscopy before and after the opsonization of cells with anti-T-H antibodies. The oxidative burst induced by adhesion of PMNs to the cells was determined by the activation of myeloperoxidase. Quantitative and qualitative changes in the release of T-H under the adhesion of activated PMNs were determined by dot-blot and Western blot analysis.
RESULTS: No binding of neutrophils to cell-surface-anchored T-H was observed. On the contrary, the opsonization of cells with anti-T-H antibodies resulted in a dramatic adhesion of neutrophils. Such an adhesion induced the oxidative burst of PMNs and a large increment in the release of T-H, as well as the release of the slightly faster migrating T-H form, which is normally retained intracellularly.
CONCLUSIONS: These results support the notion that, after the autoimmune response, the adhesion of neutrophils to cell-surface T-H contributes to the pathogenesis of tubulointerstitial nephritis, favoring a further accumulation of T-H in the interstitium and inducing the loss of cell integrity via reactive oxygen metabolites generated by activated neutrophils.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10231441     DOI: 10.1046/j.1523-1755.1999.00439.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

Review 1.  Uromodulin in kidney injury: an instigator, bystander, or protector?

Authors:  Tarek M El-Achkar; Xue-Ru Wu
Journal:  Am J Kidney Dis       Date:  2012-01-23       Impact factor: 8.860

2.  Tamm-Horsfall Protein Regulates Mononuclear Phagocytes in the Kidney.

Authors:  Radmila Micanovic; Shehnaz Khan; Danielle Janosevic; Maya E Lee; Takashi Hato; Edward F Srour; Seth Winfree; Joydeep Ghosh; Yan Tong; Susan E Rice; Pierre C Dagher; Xue-Ru Wu; Tarek M El-Achkar
Journal:  J Am Soc Nephrol       Date:  2017-11-27       Impact factor: 10.121

3.  Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism.

Authors:  Marcus D Säemann; Thomas Weichhart; Maximilian Zeyda; Günther Staffler; Michael Schunn; Karl M Stuhlmeier; Yuri Sobanov; Thomas M Stulnig; Shizuo Akira; Alexander von Gabain; Uwe von Ahsen; Walter H Hörl; Gerhard J Zlabinger
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

4.  Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes.

Authors:  B Kreft; W J Jabs; T Laskay; M Klinger; W Solbach; S Kumar; G van Zandbergen
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

5.  Urinary uromodulin, kidney function, and cardiovascular disease in elderly adults.

Authors:  Pranav S Garimella; Mary L Biggs; Ronit Katz; Joachim H Ix; Michael R Bennett; Prasad Devarajan; Bryan R Kestenbaum; David S Siscovick; Majken K Jensen; Michael G Shlipak; Paulo H M Chaves; Mark J Sarnak
Journal:  Kidney Int       Date:  2015-07-08       Impact factor: 10.612

6.  Interaction of uromodulin and complement factor H enhances C3b inactivation.

Authors:  Maojing Liu; Yaqin Wang; Fengmei Wang; Min Xia; Ying Liu; Yuqing Chen; Ming-Hui Zhao
Journal:  J Cell Mol Med       Date:  2016-04-26       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.